Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Robin L. Smith

Robin L. Smith

NeoStem® is the first company to provide adult stem cell collection and banking services to the general adult population.
TwitterBlog
RT @Stem_Cell_Dir: Scientists to test artificial blood made from human #stemcells http://www.business-standard.com/article...
Be sure to listen to the exclusive, live interview with $NBS CEO today at 2:30pm EDT on @ClearChannel. http://m.yahoo.com/w...
$NBS CEO Dr. Robin Smith comments on the Company's planned acquisition of California Stem Cell, Inc. http://www.neostem.com/media...
.@CAStemCell's Phase 3 ready asset is an exciting planned development for $NBS. Learn more in Dr. Smith's latest blog http://www.thechairmansblog.com/neostem...
Today at 2:30pm EDT Dr. Robin Smith will be interviewed on @ClearChannel's "The Traders Network Show". http://m.yahoo.com/w... $NBS
Tune in to @ClearChannel today at 2:30pm EDT to hear CEO Dr. Smith discuss $NBS' planned acquisition of @CAStemCell http://m.yahoo.com/w...
Our proposed @CAStemCell acquisition expands our pipeline of #celltherapy products to include #cancer therapies. http://www.neostem.com/media... $NBS
Chairman & CEO Dr. Smith shares Neostem's plans for continued growth in her new blog http://www.thechairmansblog.com/neostem... $NBS @ChairmansBlog
Our CEO, Dr. Robin Smith, shares her excitement about NeoStem’s plan to acquire @CAStemCell: http://www.thechairmansblog.com/neostem... $NBS
With the planned acquisition of @CAStemCell, $NBS expects to initiate a pivotal Phase 3 trial of Melapuldencel-T. http://www.neostem.com/media...
Visit the @ChairmansBlog to read Dr. Robin Smith's most recent post on Company plans to acquire @CAStemCell: http://www.thechairmansblog.com/neostem... $NBS
We plan to acquire California Stem Cell, Inc, which already has a Phase 3 ready asset. http://www.neostem.com/media... $NBS
Learn more about our agreement to acquire @CAStemCell, a company w/ a unique science & approach to immunotherapy http://www.neostem.com/media... $NBS
If you are unable to join our call on Monday, an archive will be available approx. 2 hrs after its completion http://www.neostem.com/media... $NBS
NeoStem Announces Definitive Agreement to Acquire California Stem Cell, Inc. http://www.neostem.com/media... $NBS
$NBS conference call & webcast will take place on Monday, April 14, at 10:00 AM EDT. http://www.neostem.com/media...
We will host a conference call & webcast on Monday, April 14, at 10:00 AM EDT. For more info: http://www.neostem.com/media... $NBS
NeoStem Announces Conference Call and Webcast http://www.neostem.com/media... $NBS
.@themicrx we appreciate your support of $NBS!
.@themtcrx we appreciate your support of $NBS!
Chairman & CEO Dr. Smith presents NeoStem's 2014 Outlook and Company milestones in her new blog: http://www.thechairmansblog.com/neostem... $NBS @ChairmansBlog
Our Chairman & CEO Dr. Robin Smith writes about NeoStem's milestones for 2014 in her new blog, read it here: http://www.thechairmansblog.com/neostem... $NBS
Can adult #stemcells help the heart regain its strength? Learn more about our Phase 2 PreSERVE trial from @NC5: http://www.newschannel5.com/story... $NBS
An Update from Dr. Robin Smith, Chairman and CEO http://www.thechairmansblog.com/neostem... $NBS
Dr. Adel Nada joins the $NBS team as the VP, Immunotherapy and will lead our T Regulatory Cell Program. http://www.neostem.com/media...
Dr. Douglas Losordo, CMO of $NBS commented “We are very pleased that Dr. Nada has joined us" http://www.neostem.com/media...
$NBS is pleased to add Dr. Adel Nada to our team as VP, Immunotherapy. http://www.neostem.com/media...
We welcome Dr. Adel Nada to our team as VP, Immunotherapy leading our T Regulatory Cell Program. http://www.neostem.com/media... $NBS
NeoStem Welcomes Dr. Adel Nada as Vice President, Immunotherapy http://www.neostem.com/media... $NBS
Check out all of the confernces we will be presenting at this April: http://www.neostem.com/media... @PCTcelltherapy $NBS
Other ways to read this feed:Feed readerFacebook